Skip to main content
  • Novel Oral LDL Drug Helps, If Modestly

    Pivotal trial for bempedoic acid sets up a mild-mannered contender

    Novel oral drug bempedoic acid safely but modestly reduced LDL when added to maximally-tolerated statin therapy, the CLEAR Harmony pivotal trial showed.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details